Literature DB >> 10944533

Inhibition of Wnt signaling pathway by a novel axin-binding protein.

T Kadoya1, S Kishida, A Fukui, T Hinoi, T Michiue, M Asashima, A Kikuchi.   

Abstract

Axin forms a complex with adenomatous polyposis coli gene product, glycogen synthase kinase-3beta (GSK-3beta), beta-catenin, Dvl, and protein phosphatase 2A and functions as a scaffold protein in the Wnt signaling pathway. In the Axin complex, GSK-3beta efficiently phosphorylates beta-catenin, which is then ubiquitinated and degraded by proteasome. We isolated a novel protein that binds to Axin and named it Axam (for Axin associating molecule). Axam formed a complex with Axin in intact cells and bound directly to Axin. Axam inhibited the complex formation of Dvl with Axin and the activity of Dvl to suppress GSK-3beta-dependent phosphorylation of Axin. Furthermore, Axam induced the degradation of beta-catenin in SW480 cells and inhibited Wnt-dependent axis duplication in Xenopus embryos. These results suggest that Axam regulates the Wnt signaling pathway negatively by inhibiting the binding of Dvl to Axin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944533     DOI: 10.1074/jbc.M005984200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein.

Authors:  S Hino; S Kishida; T Michiue; A Fukui; I Sakamoto; S Takada; M Asashima; A Kikuchi
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.

Authors:  Hong Zhang; Hisato Saitoh; Michael J Matunis
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

3.  The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma.

Authors:  Kruttika Bhat; Mohammad Saki; Erina Vlashi; Fei Cheng; Sara Duhachek-Muggy; Claudia Alli; Garrett Yu; Paul Medina; Ling He; Robert Damoiseaux; Matteo Pellegrini; Nathan R Zemke; Phioanh Leia Nghiemphu; Timothy F Cloughesy; Linda M Liau; Harley I Kornblum; Frank Pajonk
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-01       Impact factor: 11.205

4.  Destabilization of heterologous proteins mediated by the GSK3β phosphorylation domain of the β-catenin protein.

Authors:  Yuhan Kong; Hongyu Zhang; Xian Chen; Wenwen Zhang; Chen Zhao; Ning Wang; Ningning Wu; Yunfeng He; Guoxin Nan; Hongmei Zhang; Sheng Wen; Fang Deng; Zhan Liao; Di Wu; Junhui Zhang; Xinyue Qin; Rex C Haydon; Hue H Luu; Tong-Chuan He; Lan Zhou
Journal:  Cell Physiol Biochem       Date:  2013-11-14

5.  SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.

Authors:  Motomasa Ihara; Hideki Yamamoto; Akira Kikuchi
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

6.  Control of adipogenesis by the SUMO-specific protease SENP2.

Authors:  Sung Soo Chung; Byung Yong Ahn; Min Kim; Hye Hun Choi; Ho Seon Park; Shinae Kang; Sang Gyu Park; Young-Bum Kim; Young Min Cho; Hong Kyu Lee; Chin Ha Chung; Kyong Soo Park
Journal:  Mol Cell Biol       Date:  2010-03-01       Impact factor: 4.272

Review 7.  Diversity of axin in signaling pathways and its relation to colorectal cancer.

Authors:  Nighat Parveen; Mahboob Ul Hussain; Arshad A Pandith; Syed Mudassar
Journal:  Med Oncol       Date:  2010-10-30       Impact factor: 3.064

Review 8.  Advances of Wnt signalling pathway in dental development and potential clinical application.

Authors:  Xi Lu; Jun Yang; Shouliang Zhao; Shangfeng Liu
Journal:  Organogenesis       Date:  2019-09-04       Impact factor: 2.500

9.  Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of beta-catenin.

Authors:  Takayuki Kadoya; Hideki Yamamoto; Toshiaki Suzuki; Akira Yukita; Akimasa Fukui; Tatsuo Michiue; Toshimasa Asahara; Keiji Tanaka; Makoto Asashima; Akira Kikuchi
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

10.  Sumoylation is involved in beta-catenin-dependent activation of Tcf-4.

Authors:  Hideki Yamamoto; Motomasa Ihara; Yoshiharu Matsuura; Akira Kikuchi
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.